戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ime and a high rate of nosocomial infections antemortem.
2                  All patients were diagnosed antemortem.
3 rocognitive data were taken within 48 months antemortem.
4 opsy specimens and nasal brushings collected antemortem.
5  on intracardiac thrombus has been evaluated antemortem.
6 authors identified 54 subjects who underwent antemortem (1)H MR spectroscopy and were clinically heal
7                                              Antemortem (1)H MR spectroscopy metabolite changes corre
8 = 41, 16 females and 25 males) who underwent antemortem (1)H-MRS of the posterior cingulate gyrus at
9 dy was to compare the diagnostic accuracy of antemortem (11) C-Pittsburgh compound B (PIB) and (18) F
10 d substantia nigra neuronal loss (SNnl) with antemortem (18)F-FDG PET hypometabolism in patients with
11                         We sought to compare antemortem 18F-flortaucipir PET to neuropathology in a c
12 ears), all of whom were reported to have had antemortem acute chest pain, were imaged with postmortem
13 ibody assays for autoimmunity were performed antemortem after her islet transplantations to test in v
14 ation on the 120 patients who were diagnosed antemortem and agreed to participate in this study.
15 he sensitivity for detection of CWD prion in antemortem and environmental samples.
16                                  The odds of antemortem and perimortem trauma were low for both sexes
17 ation than those who had received discordant antemortem and postmortem diagnoses (adjusted odds ratio
18              Three had a COVID-19+ diagnosis antemortem, and 5 more were identified postmortem using
19 further support the use of RAMALTs collected antemortem as an adjunct to testing of tonsil biopsy spe
20                    Postmortem specimens from antemortem assessed and diagnosed elderly patients with
21 tly in the dorsolateral prefrontal cortex of antemortem-assessed and neuropathologically characterize
22                    By combining longitudinal antemortem assessments of psychosocial factors with post
23     Patients had not been given standardised antemortem assessments.
24  29 of these 34 cases were diagnosed as FTLD antemortem based on the sum of clinical, neuropsychologi
25    Our findings underscore the importance of antemortem biomarkers for detecting mixed pathology.
26                               The search for antemortem biomarkers is intense and has focused on cere
27                                  Identifying antemortem biomarkers of LBD stage may provide important
28 gnosed with a terminal illness and collected antemortem blood and postmortem tissues across 33 anatom
29 05 intact FL env sequences were recovered in antemortem blood cells and across 28 tissues (IQR: 5-9).
30 btained from three HIV-infected subjects and antemortem blood samples obtained from one of these subj
31                                              Antemortem blood testing revealed that the patient had u
32  mononuclear cells obtained 21 and 22 months antemortem, but was not present in samples obtained 4 an
33              To test the hypotheses that (1) antemortem cerebrospinal fluid (CSF) tau levels correlat
34  MBIs were strongly associated with the last antemortem CF score; this was significantly mediated by
35 udy describing a lack of correlation between antemortem clinical and laboratory findings and postmort
36  of this article is to study the accuracy of antemortem clinical diagnoses of frontotemporal lobar de
37                                          The antemortem clinical diagnoses were Alzheimer disease dem
38 tional aspect of medical autopsy (confirming antemortem clinical diagnoses).
39                           MITS, coupled with antemortem clinical information, provides detailed insig
40 copathological presentation and longitudinal antemortem clinical progression.
41  to IV stages of tau pathology but divergent antemortem cognition (dementia vs resilient) and cogniti
42 eraction pathways, and correlate with better antemortem cognition and reduced AD neuropathology.
43 history of methamphetamine use, considerable antemortem cognitive impairment and abundant astrogliosi
44 ted with milder AD pathology and less severe antemortem cognitive impairment compared to APOEepsilon3
45 al cohort study used cross-sectional data on antemortem cognitive performance and postmortem neuropat
46  was cross-sectionally associated with lower antemortem cognitive performance and social activity amo
47                                              Antemortem cognitive test scores inversely correlated wi
48  were compared between groups and related to antemortem cognitive testing.
49 from brain biopsy tissue collected 33 months antemortem, confirming a chronic infection despite a rob
50                                          The antemortem consensus diagnosis of FTLD was moderately se
51        Materials and Methods After obtaining antemortem consent and institutional review board approv
52                                              Antemortem consent was obtained from all study participa
53                           For a test cohort, antemortem CSF proteins from 34 AD and 34 non-AD patient
54  proteinopathy (n = 49), or AD (n = 26) with antemortem CSF.
55                       All patients underwent antemortem CT and autopsy between March 9 and April 30,
56 ed in peripheral colonization as detected by antemortem culture of feces and postmortem (320 days pos
57 re seen in the lung tissue of patients whose antemortem cultures were negative for mycobacteria.
58 hose of 18 patients with CF who had negative antemortem cultures.
59                                              Antemortem CXR were classified by three B readers using
60 tex of older adults (n = 424) in relation to antemortem depressive symptoms.
61                                              Antemortem detection of Mycoplasma hyopneumoniae infecti
62 e of PCR amplification of oral swabs for the antemortem detection of Pneumocystis in 12 rat groups fr
63                                     Based on antemortem diagnoses, demented and nondemented subjects
64                      In those with incorrect antemortem diagnoses, three were thought to have Alzheim
65 equently found as confirmation of a probable antemortem diagnosis (n = 11/21, 52%) despite receiving
66 aerophobia was significantly associated with antemortem diagnosis (odds ratio, 11.0 [95% CI, 1.05 to
67                                              Antemortem diagnosis obviates challenges associated with
68             In contrast, among those with an antemortem diagnosis of dementia, NFTs had the strongest
69                None of the decedents with an antemortem diagnosis of dilated cardiomyopathy fulfilled
70 ntity, identify imaging modalities to aid in antemortem diagnosis of ICA and to establish the optimal
71 e likely to lead to novel strategies for the antemortem diagnosis of LB disorders as well as to insig
72  observations may eventually help to improve antemortem diagnosis of neuropathology in PPA.
73                                     Accurate antemortem diagnosis of parkinsonism is primarily based
74   All cases of chronic blast exposure had an antemortem diagnosis of post traumatic stress disorder.
75 A in urine points to its potential value for antemortem diagnosis of prion diseases.
76                                          The antemortem diagnosis of rabies in humans employs techniq
77        We established two procedures for the antemortem diagnosis of sCJD subtype using diffusion mag
78  provides the first practical algorithms for antemortem diagnosis of sCJD subtypes.
79  the unique manifestations of FTLD, accurate antemortem diagnosis was feasible.
80           To investigate specific methods of antemortem diagnosis, the antibody responses of infected
81 idly spreading prion disease of cervids, yet antemortem diagnosis, treatment, and control remain elus
82 ggesting this sample type is a candidate for antemortem diagnosis.
83 ting the development of serologic assays for antemortem diagnosis.
84 ting point for future efforts to generate an antemortem diagnostic for AD.
85 LDL and LDL particles can be adapted into an antemortem diagnostic test for prions in the blood of hu
86                          The best documented antemortem diagnostic test involving RT-QuIC analysis ta
87 amination of this type of tissue as a viable antemortem diagnostic test.
88 ry-induced neurodegeneration are unknown and antemortem diagnostic tests are not available, neuropath
89                                              Antemortem ECGs were available for 5 SADS probands, 1 of
90                                              Antemortem electrodiagnostics and radiologic imaging ind
91                                        Thus, antemortem examination with the CDV FAT on external epit
92 f devices obtained through postmortem versus antemortem explantation or whether explantation was due
93                                              Antemortem findings were then compared to results from a
94  specimens and nasal brush samples collected antemortem from farmed white-tailed deer (n= 409).
95 ociation of micro brain infarcts (MBIs) with antemortem global cognitive function (CF), and whether b
96 ease spectrum pathological diagnosis who had antemortem head MRI scans between Jan 1, 1999, and Dec 3
97 er in recipients whose DCD donors were given antemortem heparin (P = 0.62).
98 tory death determination frequently involves antemortem heparin administration to mitigate peri-arres
99              To explore associations between antemortem heparin and transplant outcomes (objective 2)
100                               In conclusion, antemortem heparin practices vary substantially with an
101  compared liver transplants with and without antemortem heparin reported lower rates of primary nonfu
102 location of withdrawal and administration of antemortem heparin, are thought to play important roles
103          Given the controversies surrounding antemortem heparin, clinical trials may be warranted.
104 e care unit or operating theater) and use of antemortem heparin.
105                                              Antemortem histopathology suggested disseminated Pythium
106                                              Antemortem human rabies testing is highly sensitive when
107 ommon in neurodegenerative disease; however, antemortem imaging rarely captures copathologic effects
108  new-onset psychiatric disorders, as well as antemortem imaging studies subsequently confirmed with p
109 thromboembolism was not clinically suspected antemortem in any of the patients.
110 ossible for physicians to make the diagnosis antemortem in the time available, despite appropriate in
111 s for Alzheimer's disease (AD), representing antemortem indicators of AD pathophysiology, have greatl
112                                  Analysis of antemortem infection dynamics demonstrated that the subc
113                                              Antemortem infection is a risk factor for sudden infant
114 able alternative to DBD transplantation, and antemortem interventions including heparinization may be
115 y remains the gold-standard diagnostic tool, antemortem laboratory testing can be performed to aid in
116                               By integrating antemortem longitudinal blood signatures and spatial sin
117 post-mortem beta-amyloid and tau, as well as antemortem longitudinal cognition.
118 c mouse model and postmortem ventricular and antemortem lumbar CSF from AD patients.
119 rtem pathology was inversely associated with antemortem magnetic resonance imaging cortical thickness
120      Occipital hypometabolism is a potential antemortem marker to distinguish DLB versus AD.
121                                      Seeking antemortem markers to distinguish Dementia with Lewy bod
122 n brain tissue were significantly related to antemortem measures of global cognitive function, memory
123 med 93% of all 336 diagnoses identified from antemortem medical records, and medical autopsy confirme
124  in fatal cases of pneumonia and can confirm antemortem microbiological diagnoses.
125       We studied 46 individuals who had both antemortem MRI and an autopsy.
126          We included 407 individuals with an antemortem MRI and post-mortem brain tissue from the May
127            We leveraged a dataset comprising antemortem MRI and postmortem histopathology to assess p
128                    AIDP was also paired with antemortem MRI to test against postmortem neuropathology
129 ; n = 6) or saline (n = 6) was examined with antemortem MRI.
130                 Most missing teeth were lost antemortem (n = 283; 87%).
131 nique cohort of 98 individuals, we collected antemortem neuroimaging and genetic data, as well as pos
132 and evaluation of potential correlation with antemortem neuroimaging findings are key priorities.
133 = 5), converging evidence was obtained using antemortem neuroimaging measures of gray and white matte
134 ovative deep-learning framework in detecting antemortem neuroimaging signatures linked to different p
135 clinical symptoms and degeneration on serial antemortem neuroimaging, directly correlated with diseas
136 yndrome before their death and related their antemortem neuropsychological performance to postmortem
137 chaeological contexts, comparing exposure to antemortem (nonlethal) and perimortem (potentially letha
138 n this case series, patients with a positive antemortem or post-mortem SARS-CoV-2 result were conside
139        In cases of sudden unexplained death (antemortem or postmortem analysis of the deceased not pe
140 d in brain relate to potentially confounding antemortem or postmortem factors are difficult to prove.
141 rkinson's disease brain were also evident in antemortem peripheral blood, and correlated with clinica
142 s and bulk RNA sequencing data obtained from antemortem peripheral blood.
143                                 In cohort 1, antemortem plasma P-tau217 differentiated neuropathologi
144 o-death times ranging from 3 to 47 days, and antemortem plasma samples from 6 of these cases were eva
145 re diffuse Lewy body disease [DLBD]) who had antemortem position emission tomography imaging and auto
146                                              Antemortem prediction of CBD will remain challenging unt
147 d 41 women (median age, 60 years); 68.2% had antemortem respiratory symptoms and 30.3% were people wi
148                                      Data on antemortem risk factors were available for 93 of these p
149 gnostic sensitivity associated with specific antemortem sample types and timing of collection.
150                           Among cases with 4 antemortem sample types tested, combined diagnostic sens
151                       Among cases with fewer antemortem sample types tested, diagnostic sensitivity w
152 PrP(CWD)in rectal biopsy specimens and other antemortem samples and, with further research to identif
153 r large-scale and rapid automated testing of antemortem samples for CWD.
154 cluded 69 human rabies cases, from which 382 antemortem samples were tested.
155 homogenate and lung lavage fluid, as well as antemortem samples, such as serum.
156 velopment of sensitive diagnostic assays and antemortem sampling techniques crucial for the mitigatio
157 velopment of sensitive diagnostic assays and antemortem sampling techniques crucial for the mitigatio
158 ntification of anti-P. carinii antibodies in antemortem serum samples is a sufficiently sensitive met
159 8 patients with cystic fibrosis (CF) who had antemortem sputum cultures positive for nontuberculous m
160 eralized postmortem pathology that relate to antemortem structural imaging and distinct language defi
161              We related digital pathology to antemortem structural neuroimaging and specific clinical
162 ria for AD but show no synapse loss or overt antemortem symptoms of dementia.
163 ntia (VD) and Lewy body dementia (LBD) using antemortem T1-weighted MRI scans of 423 demented and 361
164 h, no recent hospitalization, and no current antemortem TB or COVID-19 diagnosis were identified betw
165 acenta for PrP-res could be the basis for an antemortem test for sheep scrapie, and show that PrP-res
166                                Understanding antemortem test sensitivity per sample type and timing o
167 Prevention (CDC) from 1990 through 2024 with antemortem testing on at least one of four recommended s
168 -QuIC would be comparable to IHC analysis in antemortem tissues and would correlate with both the gen
169                         However, the odds of antemortem trauma were consistently higher for males tha
170         Multimodal imaging that was obtained antemortem was matched with ex vivo and high-resolution
171             Of these, 15 (7%) were diagnosed antemortem with dilated cardiomyopathy (n=8) or ACM (n=7
172 ain tissue collected from subjects diagnosed antemortem with either no cognitive impairment, MCI, or

 
Page Top